市場調査レポート
商品コード
1459556

経皮パッチの世界市場 2024-2028

Global Transdermal Patches Market 2024-2028

出版日: | 発行: TechNavio | ページ情報: 英文 159 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
経皮パッチの世界市場 2024-2028
出版日: 2024年03月22日
発行: TechNavio
ページ情報: 英文 159 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経皮パッチ市場は2023-2028年に20億米ドル、予測期間中のCAGRは5.65%で成長すると予測されます。

当レポートでは、経皮パッチ市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、非侵襲的ドラッグデリバリー方法に対する需要の高まり、慢性疾患の有病率の増加、経皮パッチ開発への投資増加によるヘルスケア支出の増加によって牽引されています。

市場範囲
基準年 2024
終了年 2028
予測期間 2024-2028
成長モメンタム 加速
前年比2024年 4.87%
CAGR 5.65%
増分額 20億米ドル

本調査では、今後数年間の経皮パッチ市場成長を牽引する主な要因の一つとして、ドラッグデリバリー効率向上のためのマイクロニードルパッチの市場開拓を挙げています。また、経皮パッチの皮膚科学分野や化粧品分野への応用拡大、パッチ製造における持続可能で生分解性のある材料の採用は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模の評価

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023
  • 市場の見通し 2023-2028

第4章 市場規模実績

  • 経皮パッチの世界市場 2018-2022
  • 用途別セグメント分析 2018-2022
  • エンドユーザーセグメント分析 2018-2022
  • 地域別セグメント分析 2018-2022

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:用途別

  • 市場セグメント
  • 比較:用途別
  • 疼痛管理:市場規模と予測 2023-2028
  • 中枢神経系障害:市場規模と予測 2023-2028
  • ホルモン投与:市場規模と予測 2023-2028
  • 心血管疾患:市場規模と予測 2023-2028
  • その他:市場規模と予測 2023-2028
  • 市場機会:用途別

第7章 市場セグメンテーション:エンドユーザー別

  • 市場セグメント
  • 比較:エンドユーザー別
  • 在宅ケア:市場規模と予測 2023-2028
  • 病院と診療所:市場規模と予測 2023-2028
  • 市場機会:エンドユーザー別

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2023-2028
  • 欧州:市場規模と予測 2023-2028
  • アジア:市場規模と予測 2023-2028
  • 世界のその他の地域:市場規模と予測 2023-2028
  • 米国:市場規模と予測 2023-2028
  • 中国:市場規模と予測 2023-2028
  • ドイツ:市場規模と予測 2023-2028
  • 英国:市場規模と予測 2023-2028
  • 日本:市場規模と予測 2023-2028
  • 市場機会:地域別

第10章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第11章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Agile Therapeutics Inc.
  • Alvogen Iceland ehf
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Endo International Plc
  • Hisamitsu Pharmaceutical Co. Inc.
  • IontoPatch
  • Johnson and Johnson Services Inc.
  • Lead Chemical Co. Ltd.
  • Luye Pharma Group Ltd.
  • Nitto Denko Corp.
  • Novartis AG
  • Purdue Pharma LP
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market by Geography
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Historic Market Size - Data Table on global transdermal patches market 2018 - 2022 ($ billion)
  • Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
  • Exhibits20: Historic Market Size - End User Segment 2018 - 2022 ($ billion)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • Exhibits22: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits23: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits24: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits25: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits28: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits29: Chart on Application - Market share 2023-2028 (%)
  • Exhibits30: Data Table on Application - Market share 2023-2028 (%)
  • Exhibits31: Chart on Comparison by Application
  • Exhibits32: Data Table on Comparison by Application
  • Exhibits33: Chart on Pain management - Market size and forecast 2023-2028 ($ billion)
  • Exhibits34: Data Table on Pain management - Market size and forecast 2023-2028 ($ billion)
  • Exhibits35: Chart on Pain management - Year-over-year growth 2023-2028 (%)
  • Exhibits36: Data Table on Pain management - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Chart on Central nervous system disorders - Market size and forecast 2023-2028 ($ billion)
  • Exhibits38: Data Table on Central nervous system disorders - Market size and forecast 2023-2028 ($ billion)
  • Exhibits39: Chart on Central nervous system disorders - Year-over-year growth 2023-2028 (%)
  • Exhibits40: Data Table on Central nervous system disorders - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Chart on Hormonal application - Market size and forecast 2023-2028 ($ billion)
  • Exhibits42: Data Table on Hormonal application - Market size and forecast 2023-2028 ($ billion)
  • Exhibits43: Chart on Hormonal application - Year-over-year growth 2023-2028 (%)
  • Exhibits44: Data Table on Hormonal application - Year-over-year growth 2023-2028 (%)
  • Exhibits45: Chart on Cardiovascular diseases - Market size and forecast 2023-2028 ($ billion)
  • Exhibits46: Data Table on Cardiovascular diseases - Market size and forecast 2023-2028 ($ billion)
  • Exhibits47: Chart on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
  • Exhibits48: Data Table on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
  • Exhibits49: Chart on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibits50: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibits51: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits53: Market opportunity by Application ($ billion)
  • Exhibits54: Data Table on Market opportunity by Application ($ billion)
  • Exhibits55: Chart on End-user - Market share 2023-2028 (%)
  • Exhibits56: Data Table on End-user - Market share 2023-2028 (%)
  • Exhibits57: Chart on Comparison by End-user
  • Exhibits58: Data Table on Comparison by End-user
  • Exhibits59: Chart on Homecare - Market size and forecast 2023-2028 ($ billion)
  • Exhibits60: Data Table on Homecare - Market size and forecast 2023-2028 ($ billion)
  • Exhibits61: Chart on Homecare - Year-over-year growth 2023-2028 (%)
  • Exhibits62: Data Table on Homecare - Year-over-year growth 2023-2028 (%)
  • Exhibits63: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
  • Exhibits64: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
  • Exhibits65: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Exhibits66: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Exhibits67: Market opportunity by End-user ($ billion)
  • Exhibits68: Data Table on Market opportunity by End-user ($ billion)
  • Exhibits69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits70: Chart on Market share by geography 2023-2028 (%)
  • Exhibits71: Data Table on Market share by geography 2023-2028 (%)
  • Exhibits72: Chart on Geographic comparison
  • Exhibits73: Data Table on Geographic comparison
  • Exhibits74: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits75: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits76: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits77: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits79: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits80: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits81: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits82: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits83: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits84: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits86: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits87: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits88: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits90: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits91: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits92: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits94: Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits95: Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits96: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits98: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits99: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits100: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits102: Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits103: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits104: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits106: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
  • Exhibits107: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
  • Exhibits108: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits109: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits110: Market opportunity by geography ($ billion)
  • Exhibits111: Data Tables on Market opportunity by geography ($ billion)
  • Exhibits112: Impact of drivers and challenges in 2023 and 2028
  • Exhibits113: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits114: Overview on factors of disruption
  • Exhibits115: Impact of key risks on business
  • Exhibits116: Vendors covered
  • Exhibits117: Matrix on vendor position and classification
  • Exhibits118: Agile Therapeutics Inc. - Overview
  • Exhibits119: Agile Therapeutics Inc. - Product / Service
  • Exhibits120: Agile Therapeutics Inc. - Key offerings
  • Exhibits121: Alvogen Iceland ehf - Overview
  • Exhibits122: Alvogen Iceland ehf - Product / Service
  • Exhibits123: Alvogen Iceland ehf - Key offerings
  • Exhibits124: Bayer AG - Overview
  • Exhibits125: Bayer AG - Business segments
  • Exhibits126: Bayer AG - Key news
  • Exhibits127: Bayer AG - Key offerings
  • Exhibits128: Bayer AG - Segment focus
  • Exhibits129: Boehringer Ingelheim International GmbH - Overview
  • Exhibits130: Boehringer Ingelheim International GmbH - Business segments
  • Exhibits131: Boehringer Ingelheim International GmbH - Key news
  • Exhibits132: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibits133: Boehringer Ingelheim International GmbH - Segment focus
  • Exhibits134: Endo International Plc - Overview
  • Exhibits135: Endo International Plc - Business segments
  • Exhibits136: Endo International Plc - Key news
  • Exhibits137: Endo International Plc - Key offerings
  • Exhibits138: Endo International Plc - Segment focus
  • Exhibits139: Hisamitsu Pharmaceutical Co. Inc. - Overview
  • Exhibits140: Hisamitsu Pharmaceutical Co. Inc. - Product / Service
  • Exhibits141: Hisamitsu Pharmaceutical Co. Inc. - Key offerings
  • Exhibits142: IontoPatch - Overview
  • Exhibits143: IontoPatch - Key offerings
  • Exhibits144: Johnson and Johnson Services Inc. - Overview
  • Exhibits145: Johnson and Johnson Services Inc. - Business segments
  • Exhibits146: Johnson and Johnson Services Inc. - Key news
  • Exhibits147: Johnson and Johnson Services Inc. - Key offerings
  • Exhibits148: Johnson and Johnson Services Inc. - Segment focus
  • Exhibits149: Lead Chemical Co. Ltd. - Overview
  • Exhibits150: Lead Chemical Co. Ltd. - Product / Service
  • Exhibits151: Lead Chemical Co. Ltd. - Key offerings
  • Exhibits152: Luye Pharma Group Ltd. - Overview
  • Exhibits153: Luye Pharma Group Ltd. - Business segments
  • Exhibits154: Luye Pharma Group Ltd. - Key offerings
  • Exhibits155: Luye Pharma Group Ltd. - Segment focus
  • Exhibits156: Nitto Denko Corp. - Overview
  • Exhibits157: Nitto Denko Corp. - Business segments
  • Exhibits158: Nitto Denko Corp. - Key offerings
  • Exhibits159: Nitto Denko Corp. - Segment focus
  • Exhibits160: Novartis AG - Overview
  • Exhibits161: Novartis AG - Business segments
  • Exhibits162: Novartis AG - Key news
  • Exhibits163: Novartis AG - Key offerings
  • Exhibits164: Novartis AG - Segment focus
  • Exhibits165: Purdue Pharma LP - Overview
  • Exhibits166: Purdue Pharma LP - Product / Service
  • Exhibits167: Purdue Pharma LP - Key offerings
  • Exhibits168: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits169: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits170: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits171: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits172: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits173: Viatris Inc. - Overview
  • Exhibits174: Viatris Inc. - Business segments
  • Exhibits175: Viatris Inc. - Key news
  • Exhibits176: Viatris Inc. - Key offerings
  • Exhibits177: Viatris Inc. - Segment focus
  • Exhibits178: Inclusions checklist
  • Exhibits179: Exclusions checklist
  • Exhibits180: Currency conversion rates for US$
  • Exhibits181: Research methodology
  • Exhibits182: Validation techniques employed for market sizing
  • Exhibits183: Information sources
  • Exhibits184: List of abbreviations
目次
Product Code: IRTNTR77722

The transdermal patches market is forecasted to grow by USD 2.00 bn during 2023-2028, accelerating at a CAGR of 5.65% during the forecast period. The report on the transdermal patches market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing demand for non-invasive drug delivery methods, increasing prevalence of chronic diseases, and rising healthcare expenditure owing to increasing investment in transdermal patch development.

Technavio's transdermal patches market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20244.87%
CAGR5.65%
Incremental Value$2.00bn

By Application

  • Pain management
  • Central nervous system disorders
  • Hormonal application
  • Cardiovascular diseases
  • Others

By End-user

  • Homecare
  • Hospitals and clinics

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the development of microneedle patches for enhanced drug delivery efficiency as one of the prime reasons driving the transdermal patches market growth during the next few years. Also, the expansion of transdermal patch applications into dermatological and cosmetic fields and the adoption of sustainable and biodegradable materials in patch manufacturing will lead to sizable demand in the market.

The report on the transdermal patches market covers the following areas:

  • Transdermal patches market sizing
  • Transdermal patches market forecast
  • Transdermal patches market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transdermal patches market vendors that include Alvogen Iceland ehf, Boehringer Ingelheim International GmbH, Endo International Plc, Hisamitsu Pharmaceutical Co. Inc., IontoPatch, Johnson and Johnson Services Inc., Lead Chemical Co. Ltd., Luye Pharma Group Ltd., Medherant Ltd., Mundipharma International Ltd., Nitto Denko Corp., Novartis AG, Purdue Pharma LP, Sparsha Pharma International Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., AdhexPharma SAS, Agile Therapeutics Inc., Bayer AG, and Evernow Inc. Also, the transdermal patches market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview

2 Market Landscape

  • 2.1 Market ecosystem

3 Market Sizing

  • 3.1 Market definition
  • 3.2 Market segment analysis
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

  • 4.1 Global transdermal patches market 2018 - 2022
  • 4.2 Application Segment Analysis 2018 - 2022
  • 4.3 End User Segment Analysis 2018 - 2022
  • 4.4 Geography Segment Analysis 2018 - 2022

5 Five Forces Analysis

  • 5.1 Five forces summary
  • 5.2 Bargaining power of buyers
  • 5.3 Bargaining power of suppliers
  • 5.4 Threat of new entrants
  • 5.5 Threat of substitutes
  • 5.6 Threat of rivalry
  • 5.7 Market condition

6 Market Segmentation by Application

  • 6.1 Market segments
  • 6.2 Comparison by Application
  • 6.3 Pain management - Market size and forecast 2023-2028
  • 6.4 Central nervous system disorders - Market size and forecast 2023-2028
  • 6.5 Hormonal application - Market size and forecast 2023-2028
  • 6.6 Cardiovascular diseases - Market size and forecast 2023-2028
  • 6.7 Others - Market size and forecast 2023-2028
  • 6.8 Market opportunity by Application

7 Market Segmentation by End-user

  • 7.1 Market segments
  • 7.2 Comparison by End-user
  • 7.3 Homecare - Market size and forecast 2023-2028
  • 7.4 Hospitals and clinics - Market size and forecast 2023-2028
  • 7.5 Market opportunity by End-user

8 Customer Landscape

  • 8.1 Customer landscape overview

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • 9.2 Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • 9.4 Europe - Market size and forecast 2023-2028
  • 9.5 Asia - Market size and forecast 2023-2028
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • 9.7 US - Market size and forecast 2023-2028
  • 9.8 China - Market size and forecast 2023-2028
  • 9.9 Germany - Market size and forecast 2023-2028
  • 9.10 UK - Market size and forecast 2023-2028
  • 9.11 Japan - Market size and forecast 2023-2028
  • 9.12 Market opportunity by geography

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • 11.3 Landscape disruption
  • 11.4 Industry risks

12 Vendor Analysis

  • 12.1 Vendors covered
  • 12.2 Market positioning of vendors
  • 12.3 Agile Therapeutics Inc.
  • 12.4 Alvogen Iceland ehf
  • 12.5 Bayer AG
  • 12.6 Boehringer Ingelheim International GmbH
  • 12.7 Endo International Plc
  • 12.8 Hisamitsu Pharmaceutical Co. Inc.
  • 12.9 IontoPatch
  • 12.10 Johnson and Johnson Services Inc.
  • 12.11 Lead Chemical Co. Ltd.
  • 12.12 Luye Pharma Group Ltd.
  • 12.13 Nitto Denko Corp.
  • 12.14 Novartis AG
  • 12.15 Purdue Pharma LP
  • 12.16 Teva Pharmaceutical Industries Ltd.
  • 12.17 Viatris Inc.

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • 13.3 Currency conversion rates for US$
  • 13.4 Research methodology
  • 13.5 List of abbreviations